What is it about?
Malaria in pregnancy remains a significant public health problem resulting in morbidity and mortality for both the mother and fetus. Preventing malaria in pregnancy became a priority of the rollback malaria initiative with a three-prong approach consisting of the use of insecticide-treated bed net (ITN), effective case management, and the use of intermittent preventive treatment using Sulphadoxine-pyrimethamine during pregnancy (IPTp-SP). Intermittent preventive therapy during pregnancy with Sulphadoxine Pyrimethamine (IPTp-SP) is one of the potent strategies for preventing malaria in pregnancy.
Featured Image
Photo by Cassidy Rowell on Unsplash
Why is it important?
Factors such as the pregnant woman’s knowledge and very importantly perception or belief about IPTp-SP remains a key determinant of IPTp-SP uptake. This study assessed the knowledge and perception of nursing mothers and their uptake of IPTp-SP during pregnancy in the Ho Teaching Hospital.
Perspectives
While knowledge was average, perception of IPTp-SP was poor for the majority of the nursing mothers which might have hampered their uptake of IPTp-SP during pregnancy. It is important that continuous assessment of the individual factors affecting the uptake of IPTp-SP be done regularly to curb the negative influences on the uptake of IPTp-SP.
Dr Adekunle Sanyaolu
Read the Original
This page is a summary of: Assessing nursing mothers’ knowledge, perceptions and uptake of Sulphadoxine Pyrimethamine (IPTp-SP) during pregnancy in the Ho Teaching Hospital of the Volta Region of Ghana, PLOS Global Public Health, February 2023, PLOS,
DOI: 10.1371/journal.pgph.0000904.
You can read the full text:
Resources
Contributors
The following have contributed to this page
